Cohance Lifesciences (COHANCE.BO) Earnings Analysis
Cohance Lifesciences (COHANCE.BO) next reports earnings on 2026-08-07, consensus EPS -0.6 INR. Last quarter (2026-02-12) it missed with EPS 0.975 INR vs 2.69 INR est (-63.8%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 63.09.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does COHANCE.BO next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | -0.6 INR |
| Revenue estimate | 4.38B |
COHANCE.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-12 | 0.975 INR | 2.69 INR | -63.8% | Miss |
| 2025-11-10 | 1.92 INR | 1.55 INR | +23.9% | Beat |
| 2025-08-11 | 1.27 INR | 1.59 INR | -20.1% | Miss |
| 2024-08-09 | 2.39 INR | n/a | n/a | n/a |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
COHANCE.BO valuation and analyst view
| Trailing P/E | 63.09 |
|---|---|
| Trailing EPS | 4.676 INR |
| Price / book | 4.17 |
| Dividend yield | 0.00% |
| Market cap | 167.91B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Cohance Lifesciences (COHANCE.BO)'s next earnings date?
Cohance Lifesciences is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.6 INR and revenue estimate of 4.38B.
Did COHANCE.BO beat earnings last quarter?
In its 2026-02-12 report, COHANCE.BO posted EPS of 0.975 INR versus a 2.69 INR estimate — a miss of 63.8%.
What is COHANCE.BO's earnings track record?
Over the last 3 reported quarters with consensus data, COHANCE.BO beat estimates 1 times (33%).
What is COHANCE.BO's current P/E ratio and EPS?
COHANCE.BO trades at a trailing P/E of 63.09 on trailing EPS of 4.675569283103725 INR.
What do analysts rate COHANCE.BO?
COHANCE.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.